Phase 1 Crohn's disease trials recruiting now

All Crohn's disease trials, every phase

Other phases for Crohn's disease

Phase 1 Crohn's disease trials

• A Phase 1 Study of ATORM-C in Patients With Crohn's Disease
  NCT07822087 · Phase: Phase 1 · Ages: 19 Years to 80 Years · Sex: All (male and female) · 1 location
• A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
  NCT07632573 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
  NCT03167437 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Autologous Stem Cell Transplantation for Crohn's Disease
  NCT00692939 · Phase: Phase 1, Phase 2 · Ages: 10 Years to 60 Years · Sex: All (male and female) · 2 locations
• Beta-Hydroxybutyrate Feasibility Treating IBD
  NCT06351124 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
  NCT06754891 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 60 locations
• Clostridium Butyricum in Stenosing Crohn's Disease
  NCT07263880 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula
  NCT06636032 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease
  NCT06902987 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
  NCT06606808 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers
  NCT07672574 · Phase: Phase 1 · Ages: 30 Years to 65 Years · Sex: Male · 1 location
• Low Dose IL-2 for the Treatment of Crohn's Disease
  NCT04263831 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 80 Years · Sex: All (male and female) · 3 locations
• MSC Intratissular Injection in Crohn Disease Patients
  NCT03901235 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Microbial Restoration in Inflammatory Bowel Diseases
  NCT04970446 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
  NCT05725876 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease
  NCT05039411 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects
  NCT06715540 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: Male · 2 locations
• Stem Cell Transplantation in Crohn's Disease
  NCT04224558 · Phase: Phase 1, Phase 2 · Ages: 13 Years to 28 Years · Sex: All (male and female) · 1 location
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 260 locations
• Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease
  NCT07629245 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Treatment of Moderate to Severe Refractory Crohn's Disease
  NCT06721962 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 13 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.